VCM
OLMA icon

Versant Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Versant Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Sell
1,198
-181
-13% -$2.42K ﹤0.01% 2073
2026
Q1 		$20.6K Buy
1,379
+201
+17% +$4.47K ﹤0.01% 1807
2025
Q4 		$29.4K Sell
1,178
-245
-17% -$4.36K ﹤0.01% 1395
2025
Q3 		$13.9K Buy
1,423
+488
+52% +$2.93K ﹤0.01% 1775
2025
Q2 		$3.98K Sell
935
-668
-42% -$2.98K ﹤0.01% 2237
2025
Q1 		$6.03K Buy
1,603
+960
+149% +$4.83K ﹤0.01% 1962
2024
Q4 		$3.75K Buy
+643
New +$6.42K ﹤0.01% 1894

Other funds holding OLMA

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM

Versant Capital Management's OLMA Position: Q2 2026 in Review

Versant Capital Management reduced its Olema Pharmaceuticals (OLMA) stake by 13% in Q2 2026, selling an estimated $2.42K and leaving 1,198 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

Versant Capital Management first reported a position in OLMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $29.4K in Q4 2025. 10 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Versant Capital Management held 1,198 shares of Olema Pharmaceuticals worth $15K as of Q2 2026.
  • Versant Capital Management sold 181 Olema Pharmaceuticals shares in Q2 2026, an estimated $2.42K.
  • Olema Pharmaceuticals made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2073 holding.
  • Versant Capital Management first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Versant Capital Management's Olema Pharmaceuticals position peaked at $29.4K in Q4 2025.
  • 10 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.